Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders
US8092828B2 · kind B2 · utility
42Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 15, 2008 |
| Grant date | Jan 10, 2012 |
| Priority date | — |
| Expiry date | Apr 1, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/143333
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of cytarabine and an anthracycline. Such methods are particularly useful in the treatment of patients with advanced hematologic cancers or proliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.